DUGGAN ROBERT W — SEC insider filings
SEC reporting owner CIK 1055919. 55 insider filings on record with FilingPulse; latest filed 2026-11-20.
Transaction summary — filings shown
Covers the 50 most recent of 55 filings on record, filed 2021-07-02 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 33 legs across 26 filings — 491,392,894 shares, $701,533,134 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 77.
- Largest priced transaction: purchase of 376,489,880 shares @ $1.05 ($395,314,374) in Summit Therapeutics Inc., filed 2023-03-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | Co-Chief Executive Officer, Director, 10% owner | 17 | 7 legs · 475,614,157 sh · $545,250,040 | — | 19 |
| PULSE BIOSCIENCES, INC. (PLSE) | Director, 10% owner | 33 | 26 legs · 15,778,737 sh · $156,283,093 | — | 58 |
Insider filings — DUGGAN ROBERT W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise (M): 300,000 @ $1.06 · Option exercise (M): 300,000 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise (M): 500,000 @ $1.06 · Option exercise (M): 500,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 12,495 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 3,810,000 @ $13.12 | EDGAR |
| 2026-06-04 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 100,000 @ $14.60 | EDGAR |
| 2026-05-15 | 4/A | PULSE BIOSCIENCES, INC. (PLSE) | Purchase (P): 660,233 @ $19.69 | EDGAR |
| 2026-05-11 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Purchase (P): 660,233 @ $19.69 | EDGAR |
| 2026-01-06 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 11,232 (derivative) @ $8.76 | EDGAR |
| 2025-10-23 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 13,980,789 @ $18.74 · Grant/award (A): 266,808 @ $18.74 · Purchase (P): 26,680 @ $18.74 | EDGAR |
| 2025-09-12 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Purchase (P): 34,659 @ $14.66 · Purchase (P): 12,800 @ $14.77 · Purchase (P): 145,140 @ $14.41 | EDGAR |
| 2025-09-11 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 333,394 @ $17.68 · Purchase (P): 5,000 @ $18.07 | EDGAR |
| 2025-08-19 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 20,792 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise (M): 74,545 @ $2.64 · Option exercise (M): 74,545 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 1,040,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 9,590,558 (derivative) | EDGAR |
| 2025-04-09 | 4 | Summit Therapeutics Inc. (SMMT) | Option exercise/expiry (X): 3,985,055 @ $1.58 · Option exercise/expiry (X): 3,985,055 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 10,724 (derivative) @ $9.18 | EDGAR |
| 2024-12-18 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Option exercise/expiry (X): 5,187,824 @ $11 · Option exercise/expiry (X): 69,020 @ $11 · Option exercise/expiry (X): 49,312 @ $11 · Option exercise/expiry (X): 2,593,912 (derivative) · Option exercise/expiry (X): 2,593,912 (derivative) · Option exercise/expiry (X): 34,510 (derivative) · +3 more | EDGAR |
| 2024-12-17 | 4 | PULSE BIOSCIENCES, INC. (PLES) | Purchase (P): 45,404 @ $17.13 | EDGAR |
| 2024-12-17 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Purchase (P): 55,256 @ $17.18 | EDGAR |
| 2024-12-13 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Purchase (P): 6,054 @ $16.74 · Purchase (P): 50,000 @ $17.42 | EDGAR |
| 2024-09-13 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 3,325,991 @ $22.70 | EDGAR |
| 2024-07-09 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Option exercise/expiry (X): 5,187,824 · Option exercise/expiry (X): 69,020 · Option exercise/expiry (X): 49,312 · Purchase (P): 2,593,912 (derivative) · Purchase (P): 2,593,912 (derivative) · Purchase (P): 34,510 (derivative) · +3 more | EDGAR |
| 2024-06-24 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 16,247 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 74,545 (derivative) @ $1.32 | EDGAR |
| 2023-12-14 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 17,999 @ $9.15 | EDGAR |
| 2023-12-13 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 90,118 @ $9.36 | EDGAR |
| 2023-12-12 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 116,656 @ $9.54 | EDGAR |
| 2023-12-11 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 74,852 @ $9.19 | EDGAR |
| 2023-12-08 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise (M): 9,933 @ $5.95 · Purchase (P): 82,813 @ $9.06 · Option exercise (M): 9,933 (derivative) @ $0 | EDGAR |
| 2023-12-07 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 66,021 @ $9.34 | EDGAR |
| 2023-12-06 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise (M): 20,000 @ $10.66 · Option exercise (M): 20,347 @ $10.66 · Purchase (P): 27,000 @ $10.38 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 20,347 (derivative) @ $0 | EDGAR |
| 2023-12-05 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 45,600 @ $9.07 | EDGAR |
| 2023-12-04 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 152,944 @ $9.06 | EDGAR |
| 2023-12-01 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise (M): 1,667 @ $5.95 · Purchase (P): 158,600 @ $9.44 · Purchase (P): 60,000 @ $9.21 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2023-11-30 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 124,397 @ $8.98 | EDGAR |
| 2023-11-20 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 241 @ $6.10 · Purchase (P): 10,000 @ $6.09 · Purchase (P): 10,000 @ $6.11 | EDGAR |
| 2023-11-09 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise (M): 3,333 @ $5.95 · Option exercise (M): 9,932 @ $5.95 · Option exercise (M): 3,333 (derivative) @ $0 · Option exercise (M): 9,932 (derivative) @ $0 | EDGAR |
| 2023-08-28 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise (M): 1,667 @ $5.95 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2023-07-27 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise (M): 1,667 @ $5.95 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise (M): 65,000 @ $2.14 · Option exercise (M): 65,467 @ $2.14 · Option exercise (M): 1,666 @ $5.95 · Option exercise (M): 65,000 (derivative) @ $0 · Option exercise (M): 65,467 (derivative) @ $0 · Option exercise (M): 1,666 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise/expiry (X): 5,683,163 @ $2.05 · Option exercise/expiry (X): 81,025 @ $2.05 · Option exercise/expiry (X): 5,683,163 (derivative) @ $0 · Option exercise/expiry (X): 81,025 (derivative) @ $0 | EDGAR |
| 2023-06-06 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 39,731 (derivative) @ $0 | EDGAR |
| 2023-05-10 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 10,022,937 @ $6.51 | EDGAR |
| 2023-03-08 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 376,489,880 @ $1.05 | EDGAR |
| 2022-12-08 | 4 | Summit Therapeutics Inc. (SMMT) | Other (J): 9,346,434 | EDGAR |
| 2022-08-18 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 94,849,203 @ $0.97 | EDGAR |
| 2022-06-10 | 4 | Pulse Biosciences, Inc. (PLSE) | Option exercise/expiry (X): 5,683,163 · Option exercise/expiry (X): 81,025 · Purchase (P): 5,683,163 (derivative) · Purchase (P): 81,025 (derivative) | EDGAR |
| 2022-05-25 | 4 | Summit Therapeutics Inc. (SMMT) | Other (J): 21,135 | EDGAR |
| 2022-05-23 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 110,467 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | Pulse Biosciences, Inc. (PLSE) | Purchase (P): 3,048,780 @ $16.40 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1055919 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs